Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Prediction of lung function and lung density of young adults who had bronchopulmonary dysplasia

Helger Y. Santema, Jan Stolk, Mady Los, Berend C. Stoel, Roula Tsonaka, Istvan T. Merth
ERJ Open Research 2020 6: 00157-2020; DOI: 10.1183/23120541.00157-2020
Helger Y. Santema
1Dept of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Stolk
1Dept of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: j.stolk@lumc.nl
Mady Los
1Dept of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Berend C. Stoel
2Dept of Radiology, Leiden University Medical Center, Leiden, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roula Tsonaka
3Dept of Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Istvan T. Merth
4Dept of Pediatrics, Ziekenhuisgroep Twente, Almelo, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Figures

  • Tables
  • Supplementary Materials
  • FIGURE 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1

    Patient disposition. Flow chart of the participants. Seven healthy prematurely (HP) born infants could not be located for the study. However, one subject, who was not measured in infancy, could be included in the adult group. Three refused to participate and one moved abroad leaving 14 HP participants. Of the hyaline membrane disease (HMD) subjects, 5 could not be located at adult age leaving 14 HMD participants. Of those with bronchopulmonary dysplasia (BPD), 2 passed away during infancy, 2 could not be located, 2 have moved abroad, 3 refused to participate and 3 were severely mentally handicapped, precluding them to participate at adulthood leaving 36 BPD participants. As clinical data of HP and HMD groups revealed no differences (supplementary table S1), all data of these two groups were combined to qualify as non-BPD (non-BPD, n=28). Thus, in total, 28 non-BPD served as controls and 36 BPD subjects were analysed in the study. All HP subjects were White except for one from Indonesia and two from North African, one HMD and one BPD subject was from Indonesia.

  • FIGURE 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2

    Spirometry, gas exchange and lung density at young adulthood. Box plots for lung function parameters of 28 non-BPD subjects (dark box) and 36 BPD subjects (light box) who had spirometry, gas transfer and lung density measured. *: significant difference between groups after correction for birth weight and smoking history (p<0.005);. +: outlier.

  • FIGURE 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3

    Distribution of forced expiratory volume in 1 s (zFEV1) with and without airway obstruction in the bronchopulmonary dysplasia (BPD) group. In the BPD group (55%) had a normal zFEV1/forced vital capacity (FVC) (defined by z-score >−1.64), 16 of whom had a zFEV1 above the lower limit of normal (LLN), while those with a zFEV1/FVC below the LLN (n=15 of 33) had a mean zFEV1 of −3.09, (−4.89 to −1.22, min to max).

  • FIGURE 4
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4

    Relation between inspiratory oxygen fraction (FIO2) at 36 weeks of gestational corrected age (GCA) and forced expiratory volume in 1 s (zFEV1) or zFEV1/forced vital capacity (FVC) at adulthood. Airflow limitation (zFEV1) and airway obstruction (zFEV1/FVC) in 29 NCLD adult subjects in relation to the FIO2 at 36 weeks after conception measured while treated with oxygen administered to the spontaneously breathing infant, either in an incubator or in an oxygen tent. Regression analysis for zFEV1 revealed B=−6.4, with p=0.053, and B=−3,2, with p=0.29 for zFEV1/FVC.

Tables

  • Figures
  • Supplementary Materials
  • TABLE 1

    Perinatal characteristics and at gestational corrected age (GCA) of 1 year

    Non-BPD group (n=28)BPD group (n=36)Missing (BPD/non-BPD)p-value
    Male18/28 (64%)24/36 (67%)00.84
    Weeks of pregnancy31.0±2.628.2±2.30<0.0001
    Birth weight g1484±4401059±3340<0.0001
    Birth weight percentiles52.5±29.651.6±31.300.91
    Surfactant therapy11/28 (39%)21/36 (58%)00.13
    Prenatal dexamethasone#7/28 (25%)16/36 (44%)00.11
    Postnatal dexamethasone0/28 (0%)20/36 (56%)0<0.0001
    HMD14/28 (50%)27/36 (75%)00.036
    PIPmax8.2±10.924.7±7.55/5<0.0001
    FIO2 at 36 weeks0.210.29±0.086/0<0.0001
    GCA at lung function testing months9.7±3.810.4±3.01/10.47
    CHL at lung function testing cm71±971±72/10.73
    FRC z-score for CHL0.05±1.03)0.37±1.312/10.30
    Compliance z-score for CHL0.32±1.03−0.56±0.823/10.0005
    Mixing efficiency %56±1043±172/20.0012

    Data are presented as mean±sd or n/N (%), unless otherwise stated. Mean weeks of pregnancy and mean birth weight were significantly different between groups. GCA in months for some patients was less than 12 months because they could not be tested at GCA 12 months. Mean PIPmax: mean maximum positive inspiratory pressure during mechanical ventilation in cmH2O; mean FIO2 at 36 weeks: fractional inspired oxygen concentration in ambient air at post-conceptional age of 36 weeks; GCA: gestational corrected age; BPD: bronchopulmonary dysplasia; CHL: crown–heel length; HMD: hyaline membrane disease; PIPmax: maximum positive inspiratory pressure; FIO2: inspiratory oxygen fraction. #: Prenatal dexamethasone was administered ante partum to mothers if admitted on time before delivery to the hospital.

    • TABLE 2

      Subject characteristics at adulthood

      Non-BPD group (n=28)BPD group (n=36)Missingp-value
      Smoking4/28 (14%)7/36 (19%)00.74
      Age at lung function testing years21.0±2.519.7±1.100.0077
      Weight kg68±1269±1900.89
      Length cm177±10.3174±1000.21
      BMI kg·m−221.7±2.822.6±4.900.38

      Data are presented as mean±sd or n/N (%), unless otherwise stated. BPD: bronchopulmonary dysplasia; Smoking: ever-smoking (yes=1, no=0); BMI: body mass index kg·m−2.

      • TABLE 3

        Regression analysis of perinatal parameters on outcomes in adult BPD

        zFEV1/FVCzFEV1zDLCOSMSSGRQ
        FIO2 36w (B (p))−3.2 (0.29)−6.4 (0.053)−4.1 (0.023)−2.4 (0.36)3.7 (0.86)
        Prenatal dexa (B (p))−0.64 (0.24)0.19 (0.74)0.56 (0.069)−0.77 (0.097)4.2 (0.27)
        Birthweight g (B (p))−0.0023 (0.0091)−0.0015 (0.089)0.0097 (0.043)0.0014 (0.075)0.0065 (0.28)
        PIPmax (B (p))0.028 (0.51)0.028 (0.53)0.0020 (0.93)−0.020 (0.55)−0.093 (0.74)
        R2 adjusted (adjusted p-values of likelihood ratio test)0.20 (0.046)0.16 (0.081)0.17 (0.057)0.13 (0.10)−0.057 (0.67)

        Multiple linear regression analyses were used to determine whether neonatal parameters correlated with outcomes at adult age within the BPD group. None of the dependent variables at adulthood reached a significance level, set at p<0.0025 by Bonferroni correction. zFEV1/FVC, zFEV1, zFVC, are z-scores for adult lung function outcomes with GLI-references and zDLCO with European Community of Coal and Steel references. Prenatal dexa: ante partum dexamethasone administered to mothers (yes=1, no=0). BPD: bronchopulmonary dysplasia; FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; SMS: standard mass score for lung density; SGRQ: St. George's Respiratory Questionnaire; FIO2 36w: fractional inspired oxygen concentration in ambient air at post-conceptional age of 36 weeks; PIPmax: maximum positive inspiratory pressure during mechanical ventilation in cmH2O; DLCO: diffusing capacity of the lung for carbon monoxide.

        Supplementary Materials

        • Figures
        • Tables
        • Supplementary Material

          Please note: supplementary material is not edited by the Editorial Office, and is uploaded as it has been supplied by the author.

          Supplementary material 00157-2020.SUPPLEMENT

        PreviousNext
        Back to top
        Vol 6 Issue 4 Table of Contents
        ERJ Open Research: 6 (4)
        • Table of Contents
        • Index by author
        Email

        Thank you for your interest in spreading the word on European Respiratory Society .

        NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

        Enter multiple addresses on separate lines or separate them with commas.
        Prediction of lung function and lung density of young adults who had bronchopulmonary dysplasia
        (Your Name) has sent you a message from European Respiratory Society
        (Your Name) thought you would like to see the European Respiratory Society web site.
        CAPTCHA
        This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
        Print
        Citation Tools
        Prediction of lung function and lung density of young adults who had bronchopulmonary dysplasia
        Helger Y. Santema, Jan Stolk, Mady Los, Berend C. Stoel, Roula Tsonaka, Istvan T. Merth
        ERJ Open Research Oct 2020, 6 (4) 00157-2020; DOI: 10.1183/23120541.00157-2020

        Citation Manager Formats

        • BibTeX
        • Bookends
        • EasyBib
        • EndNote (tagged)
        • EndNote 8 (xml)
        • Medlars
        • Mendeley
        • Papers
        • RefWorks Tagged
        • Ref Manager
        • RIS
        • Zotero
        Share
        Prediction of lung function and lung density of young adults who had bronchopulmonary dysplasia
        Helger Y. Santema, Jan Stolk, Mady Los, Berend C. Stoel, Roula Tsonaka, Istvan T. Merth
        ERJ Open Research Oct 2020, 6 (4) 00157-2020; DOI: 10.1183/23120541.00157-2020
        Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
        Full Text (PDF)

        Jump To

        • Article
          • Abstract
          • Abstract
          • Introduction
          • Methods
          • Results
          • Discussion
          • Supplementary material
          • Acknowledgements
          • Footnotes
          • References
        • Figures & Data
        • Info & Metrics
        • PDF

        Subjects

        • Lung structure and function
        • Tweet Widget
        • Facebook Like
        • Google Plus One

        More in this TOC Section

        Original articles

        • Endobronchial autologous BM-MSCs in IPF patients
        • Effect of β-blockers on the risk of COPD exacerbations
        • Recurrence of symptoms after childhood LRTI
        Show more Original articles

        Lung function

        • Period and cohort effects
        • Infant lung function and physical activity in pregnancy
        • BMI increase: risk factor for FEV1 decline in asthma
        Show more Lung function

        Related Articles

        Navigate

        • Home
        • Current issue
        • Archive

        About ERJ Open Research

        • Editorial board
        • Journal information
        • Press
        • Permissions and reprints
        • Advertising

        The European Respiratory Society

        • Society home
        • myERS
        • Privacy policy
        • Accessibility

        ERS publications

        • European Respiratory Journal
        • ERJ Open Research
        • European Respiratory Review
        • Breathe
        • ERS books online
        • ERS Bookshop

        Help

        • Feedback

        For authors

        • Instructions for authors
        • Publication ethics and malpractice
        • Submit a manuscript

        For readers

        • Alerts
        • Subjects
        • RSS

        Subscriptions

        • Accessing the ERS publications

        Contact us

        European Respiratory Society
        442 Glossop Road
        Sheffield S10 2PX
        United Kingdom
        Tel: +44 114 2672860
        Email: journals@ersnet.org

        ISSN

        Online ISSN: 2312-0541

        Copyright © 2023 by the European Respiratory Society